Guobang Pharma Ltd. (605507.SH) has repurchased a total of 5.3753 million shares, spending 103 million yuan.
Guo Bang Pharmaceutical (605507.SH) announces that as of October 31, 2025, the company has successfully passed the centralized bidding...
Guobang Pharma Ltd. (605507.SH) announced that as of October 31, 2025, the company has repurchased a total of 5.3753 million shares through centralized bidding trading, representing 0.96% of the company's total share capital. The highest price at which shares were repurchased was 19.88 yuan per share, the lowest price was 18.61 yuan per share, and the total amount paid was 103 million yuan (excluding transaction costs).
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
